Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. | Pepdox

Home
Search
PMID 31747739

Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.

The New England journal of medicine2019PMID: 31747739

View on PubMed DOI: 10.1056/NEJMc1913157

Authors

Zweck, Elric; Westenfeld, Ralf; Szendroedi, Julia